Buy Udenafil

Udenafil

What is Udenafil?

Udenafil is a prescription medication used to treat erectile dysfunction (ED) in adult men. It belongs to the phosphodiesterase-type-5 (PDE5) inhibitor class, which also includes well-known agents such as sildenafil and tadalafil. The drug is supplied as a 100 mg oral pill and is regulated by the Hong Kong Department of Health as a prescription-only product. Udenafil contains the active ingredient Udenafil; it is marketed under this name in several regions.

How Udenafil Works in the Body

Udenafil blocks the enzyme phosphodiesterase-type-5 (PDE5) that normally breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle of the penis. By inhibiting PDE5, cGMP levels remain higher for longer, leading to:

• Smooth-muscle relaxation in the corpora cavernosa.
• Increased arterial blood flow toward the penile tissue.
• Facilitation of an erection in response to sexual stimulation.

The onset of action typically occurs within 30-60 minutes, with peak effects around 1-2 hours after ingestion. The drug’s effects generally last 6-12 hours, allowing flexibility for sexual activity timing. Udenafil is absorbed orally, undergoes hepatic metabolism (primarily via CYP3A4), and has a half-life of roughly 11-13 hours.

Conditions Treated by Udenafil

Udenafil is approved for the treatment of erectile dysfunction in men who experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual performance. In Hong Kong, it is available only with a doctor’s prescription and is intended for adult patients without contraindicating cardiovascular conditions.

Investigational Uses

Research interest has explored Udenafil for pulmonary arterial hypertension (PAH) because PDE5 inhibition can reduce pulmonary vascular resistance. Clinical trials are ongoing, but the drug is not approved for PAH or any other off-label indication in Hong Kong. Use for these purposes would require careful medical supervision and is considered experimental.

Who Should Not Use Udenafil?

Absolute contraindications

• Known hypersensitivity to Udenafil or any inactive ingredients.
• Concomitant use of nitrate medications (e.g., nitroglycerin, isosorbide dinitrate) because of risk of severe hypotension.
• Recent (within 14 days) stroke, myocardial infarction, or unstable angina.

Relative contraindications / special considerations

• Severe cardiovascular disease (e.g., uncontrolled hypertension, severe heart failure).
• Renal impairment (creatinine clearance < 30 mL/min) - dose may need reduction.
• Hepatic impairment (Child-Pugh class C) - consider a lower dose or avoid use.
• Use with alpha-blockers (e.g., tamsulosin) - monitor for additive blood-pressure-lowering effects.
• Pregnancy and lactation - not indicated for women; male partners should discuss with a healthcare provider if the female partner is pregnant.

Patients with underlying conditions should discuss their full medical history with a pharmacist or physician before starting Udenafil.

Safety Profile and Interactions

Common Side Effects

• Headache - frequently reported, usually mild and transient.
• Flushing - warm sensation, often on the face or neck.
• Indigestion or dyspepsia - may improve with taking the pill with food.
• Nasal congestion - occasional stuffy nose.
• Dizziness - generally mild; avoid rapid position changes if experienced.

Serious Adverse Events

• Priapism (prolonged erection > 4 hours) - requires immediate medical attention to prevent tissue damage.
• Severe hypotension - especially when combined with nitrates or potent vasodilators.
• Vision changes (e.g., sudden loss of vision in one eye) - rare but urgent.
• Hearing loss - isolated reports; seek prompt evaluation if it occurs.

Drug Interactions

• Nitrates (any formulation) - contraindicated; can cause life-threatening hypotension.
• CYP3A4 inhibitors (ketoconazole, itraconazole, erythromycin, clarithromycin, HIV protease inhibitors) - may increase Udenafil plasma levels; dose reduction or alternative therapy advised.
• CYP3A4 inducers (rifampin, carbamazepine, St. John’s wort) - may reduce effectiveness.
• Alpha-blockers - concurrent use can amplify blood-pressure drops; monitor closely.
• Other PDE5 inhibitors - combined use is not recommended due to additive risk of adverse events.

Food and Lifestyle Interactions

• High-fat meals can delay absorption, slightly reducing the speed of onset; taking the pill on an empty stomach may provide faster effect.
• Alcohol - moderate consumption is generally tolerated, but excessive intake can increase dizziness and lower blood pressure.
• Driving or operating machinery - most patients can continue normal activities, but those experiencing dizziness should exercise caution.

Patients should disclose all prescription drugs, over-the-counter medicines, supplements, and herbal products to their healthcare provider before starting Udenafil.

How to Take Udenafil

• Standard dose: 100 mg taken orally about 30 minutes before anticipated sexual activity.
• Maximum frequency: Do not exceed one dose per day.
• With food: Can be taken with or without food; high-fat meals may delay onset.
• Renal or hepatic impairment: For moderate renal or hepatic dysfunction, a lower dose (e.g., 50 mg) is often recommended, but exact adjustments should be made by a prescribing clinician.
• Missed dose: If an erection occurs, take the medication as planned. If the scheduled time is missed, skip the dose; do not double up.
• Overdose: Symptoms may include severe hypotension, fainting, prolonged erection, or rapid heart rate. Seek emergency medical care; treatment is supportive (intravenous fluids, vasopressors if needed).
• Discontinuation: No tapering is required. Stopping the medication does not cause withdrawal, but patients should discuss any ongoing erectile concerns with their provider.

Monitoring and Follow-Up

• Baseline cardiovascular assessment - prior to initiating therapy, clinicians should evaluate blood pressure, cardiac history, and overall cardiovascular risk.
• Blood pressure checks - periodic monitoring is advisable, especially for patients with pre-existing hypertension or those on antihypertensive agents.
• Symptom review - patients should report any persistent erections, visual disturbances, or severe dizziness promptly.
• Routine follow-up - typically scheduled after 4-8 weeks to assess efficacy, tolerability, and need for dose adjustment.

Storage and Handling

• Store Udenafil tablets at room temperature (20-25 °C), protected from excess moisture and heat.
• Keep the container tightly closed and out of reach of children and pets.
• Do not use the medication after the expiration date printed on the packaging.
• Dispose of unused tablets according to local pharmaceutical waste guidelines or return them to a pharmacy for safe disposal.

Medication-Specific Glossary

PDE5 Inhibitor

A drug class that blocks the phosphodiesterase-type-5 enzyme, enhancing cGMP levels and promoting smooth-muscle relaxation in the penis.

cGMP (Cyclic Guanosine Monophosphate)

A second messenger molecule that mediates vasodilation; elevated levels lead to increased blood flow to erectile tissue.

Priams

A painful erection lasting longer than four hours; considered a medical emergency because it can cause permanent tissue damage.

Bioavailability

The proportion of an oral dose that reaches systemic circulation unchanged; Udenafil has moderate oral bioavailability, which can be affected by food intake.

Medical Disclaimer

This article provides educational information about Udenafil and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.